Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Health Claims Law Includes Effect On Existing Disease – Saw Palmetto Appeal

This article was originally published in The Tan Sheet

Executive Summary

A Washington, D.C. federal court committed a "plain and reversible error" when it upheld FDA's decision to deny a health claim linking saw palmetto extract to the treatment of benign prostatic hyperplasia symptoms, according to an appellate brief filed May 16
Advertisement

Related Content

Saw Palmetto Claims Case Set For November Oral Arguments
Saw Palmetto Claims Case Set For November Oral Arguments
Saw Palmetto Claims Case Set For November Oral Arguments
AHPA saw palmetto claim
AHPA saw palmetto claim
AHPA saw palmetto claim
FDA Prohibition of Saw Palmetto/BPH Treatment Claim Upheld by Court
FDA Prohibition of Saw Palmetto/BPH Treatment Claim Upheld by Court

Topics

Advertisement
UsernamePublicRestriction

Register

PS095498

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel